A PBPK model recapitulates early kinetics of anti-PEG antibody-mediated clearance of PEG-liposomes-Reference-Cited by-同舟云学术

A PBPK model recapitulates early kinetics of anti-PEG antibody-mediated clearance of PEG-liposomes

Published:2022-03 Issue: Volume:343 Page:518-527
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Talkington Anne M.,McSweeney Morgan D.,Wessler Timothy,Rath Marielle K.,Li Zibo,Zhang Tao,Yuan Hong,Frank Jonathan E.,Forest M. Gregory,Cao Yanguang,Lai Samuel K.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference66 articles.

1. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives;Knop;Angew. Chem. Int. Ed.,2010

2. PEGylated biopharmaceuticals: current experience and considerations for nonclinical development;Ivens;Toxicol. Pathol.,2015

3. What is the future of PEGylated therapies?;Swierczewska;Exp. Opin. Emerg. Drugs,2015

4. The impact of PEGylation on protein immunogenicity;Gefen;Int. Immunopharmacol.,2013

5. The impact of PEGylation on biological therapies;Veronese;BioDrugs,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PBPK model of pegylated liposomal doxorubicin to simultaneously predict the concentration–time profile of encapsulated and free doxorubicin in tissues;Drug Delivery and Translational Research;2024-08-05

2. Influence of hydrophilic block length on the aggregation properties of polyglycidol–polystyrene–polyglycidol copolymers;Soft Matter;2024

3. Liposomes in controlled drug delivery;Liposomes in Drug Delivery;2024

4. The power of weak, transient interactions across biology: A paradigm of emergent behavior;Physica D: Nonlinear Phenomena;2023-11

5. Gout therapeutics and drug delivery;Journal of Controlled Release;2023-10